The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.
#stockmarket #breaking
FDA to limit covid shot approval to 65+, those with medical conditions – The Washington Post
